Farther Finance Advisors
LAB icon

Farther Finance Advisors’s Standard BioTools LAB Stock Holding History

Farther Finance Advisors’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.73K Buy
3,687
+2,540
+221% +$1.95K ﹤0.01% 5287
2026
Q2 		$933 Buy
1,147
+816
+247% +$771 ﹤0.01% 5394
2026
Q1 		$304 Buy
331
+323
+4,038% +$391 ﹤0.01% 5367
2025
Q4 		$10 Buy
8
+3
+60% +$4 ﹤0.01% 5412
2025
Q3 		$7 Hold
5
– – ﹤0.01% 4929
2025
Q2 		$6 Hold
5
– – ﹤0.01% 4465
2025
Q1 		$5 Sell
5
-18
-78% -$25 ﹤0.01% 4238
2024
Q4 		$40 Hold
23
– – ﹤0.01% 3886
2024
Q3 		$44 Sell
23
-9
-28% -$18 ﹤0.01% 3870
2024
Q2 		$55 Hold
32
– – ﹤0.01% 3683
2024
Q1 		$86 Buy
+32
New +$77 ﹤0.01% 3401

Other funds holding LAB

Peapod Lane Capital
Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return
DLK Investment Management
DLK Investment Management Solana Beach, California $275M AUM 10.69% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Farther Finance Advisors's LAB Position: Q3 2026 in Review

Farther Finance Advisors increased its Standard BioTools (LAB) stake by 221% in Q3 2026, buying an estimated $1.95K and bringing the position to 3,687 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #5287.

Farther Finance Advisors first reported a position in LAB in Q1 2024 and has held it in 11 quarters since. 5 funds tracked by Wall St. Rank hold LAB as of Q3 2026.

  • Farther Finance Advisors held 3,687 shares of Standard BioTools worth $2.73K as of Q3 2026.
  • Farther Finance Advisors bought 2,540 Standard BioTools shares in Q3 2026, an estimated $1.95K.
  • Standard BioTools made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5287 holding.
  • Farther Finance Advisors first reported a position in Standard BioTools in Q1 2024 and has held it in 11 quarters since.
  • 5 funds tracked by Wall St. Rank held Standard BioTools as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.